Alluna® – Ze 91019
Alluna® – Ze 91019
For the treatment of sleep disorders.
- For natural sleep on the long run
- Restoration of sleep architecture
- No drowsiness or morning hang-over
This is an authorised medicinal product.
Max Zeller Söhne AG, 8590 Romanshorn
Product information
Indication
For the treatment of sleep disorders such as difficulties in falling asleep, staying asleep as well as restless sleep (according to WHO ICD10: F51.0 – 51.2).
Extract composition
Alluna®: 250 mg dry extract of Valeriana officinalis L. root & 60 mg dry extract of Humulus lupulus L. strobile (Ze 91019)
Alluna forte®: 500 mg dry extract of Valeriana officinalis L. root & 120 mg dry extract of Humulus lupulus L. strobile (Ze 91019)
Drug-extract ratio (DER) Valeriana officinalis L.: 5-8:1
Drug-extract ratio (DER) Humulus lupuli L.: 7-10:1
Extraction solvent: 45% methanol (m/m)
Dosage
Alluna®: 2 film-coated tablets per day
Alluna forte®: 1 film-coated tablet per day
Recommended over a period of 4 weeks
Clinical Evidence & Mode of action
The information contained in this section is intended for healthcare professionals only.
Please click the button below to confirm that you are a healthcare professional.
Get in Touch
Max Zeller Soehne AG Seeblickstr. 4 8590 Romanshorn Switzerland
Ze 91019 – The Difference
Dual mode of action - Ze 91019 induces sleep pressure and regulates circadian rhythm through the adenosine and melatonin receptors. Superior to placebo and Valerian mono-therapy.
Excellent Combination – Ze 91019 reduces sleep onset and nightly awakening, increases sleep duration and improves sleep architecture.
Long-term treatment – Natural therapy suitable for long-term intake, also in elderly patients.
High safety – Well-documented safety, with no addiction potential and no risk for cognitive impairment, drowsiness, morning hang-over or drug –drug interactions.
